Human Leukocyte Antigen alleles associated with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)

被引:24
作者
Lande, Asgeir [1 ,2 ,3 ]
Fluge, Oystein [4 ,5 ]
Strand, Elin B. [6 ,7 ]
Flam, Siri T. [1 ,2 ]
Sosa, Daysi D. [8 ]
Mella, Olav [4 ,5 ]
Egeland, Torstein [3 ,9 ]
Saugstad, Ola D. [10 ]
Lie, Benedicte A. [1 ,2 ,3 ,9 ]
Viken, Marte K. [1 ,2 ,9 ]
机构
[1] Univ Oslo, Dept Med Genet, Oslo, Norway
[2] Oslo Univ Hosp, Oslo, Norway
[3] Univ Oslo, Inst Clin Med, Oslo, Norway
[4] Haukeland Hosp, Dept Oncol & Med Phys, Bergen, Norway
[5] Univ Bergen, Dept Clin Sci, Bergen, Norway
[6] Oslo Univ Hosp, Natl Advisory Unit CFS ME, Oslo, Norway
[7] VID Specialized Univ, Fac Hlth Sci, Stavanger, Norway
[8] Oslo Univ Hosp, CFS ME Ctr, Oslo, Norway
[9] Oslo Univ Hosp, Dept Immunol, Oslo, Norway
[10] Univ Oslo, Oslo Univ Hosp, Dept Pediat Res, Oslo, Norway
关键词
HLA; DISEASE; DISEQUILIBRIUM; AUTOANTIBODIES; MECHANISMS; REGION;
D O I
10.1038/s41598-020-62157-x
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The etiology and pathogenesis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) are unknown, and autoimmunity is one of many proposed underlying mechanisms. Human Leukocyte Antigen (HLA) associations are hallmarks of autoimmune disease, and have not been thoroughly investigated in a large ME/CFS patient cohort. We performed high resolution HLA -A, -B, -C, -DRB1, -DQB1 and -DPB1 genotyping by next generation sequencing in 426 adult, Norwegian ME/CFS patients, diagnosed according to the Canadian Consensus Criteria. HLA associations were assessed by comparing to 4511 healthy and ethnically matched controls. Clinical information was collected through questionnaires completed by patients or relatives. We discovered two independent HLA associations, tagged by the alleles HLA-C*07:04 (OR 2.1 [95% CI 1.4-3.1]) and HLA-DQB1*03:03 (OR 1.5 [95% CI 1.1-2.0]). These alleles were carried by 7.7% and 12.7% of ME/CFS patients, respectively. The proportion of individuals carrying one or both of these alleles was 19.2% in the patient group and 12.2% in the control group (OR 1.7 [95% CI 1.3-2.2], p(nc) = 0.00003). ME/CFS is a complex disease, potentially with a substantial heterogeneity. We report novel HLA associations pointing toward the involvement of the immune system in ME/CFS pathogenesis.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Investigating the effectiveness and cost-effectiveness of FITNET-NHS (Fatigue In Teenagers on the interNET in the NHS) compared to Activity Management to treat paediatric chronic fatigue syndrome (CFS)/myalgic encephalomyelitis (ME): protocol for a randomised controlled trial
    Baos, Sarah
    Brigden, Amberly
    Anderson, Emma
    Hollingworth, William
    Price, Simon
    Mills, Nicola
    Beasant, Lucy
    Gaunt, Daisy
    Garfield, Kirsty
    Metcalfe, Chris
    Parslow, Roxanne
    Downing, Harriet
    Kessler, David
    Macleod, John
    Stallard, Paul
    Knoop, Hans
    Van de Putte, Elise
    Nijhof, Sanne
    Bleijenberg, Gijs
    Crawley, Esther
    TRIALS, 2018, 19
  • [32] A comparison of health status in patients meeting alternative definitions for chronic fatigue syndrome/myalgic encephalomyelitis
    Johnston, Samantha C.
    Brenu, Ekua W.
    Hardcastle, Sharni L.
    Huth, Teilah K.
    Staines, Donald R.
    Marshall-Gradisnik, Sonya M.
    HEALTH AND QUALITY OF LIFE OUTCOMES, 2014, 12
  • [33] Paradigm shift to disequilibrium in the genesis of orthostatic intolerance in patients with myalgic encephalomyelitis and chronic fatigue syndrome
    Miwa, Kunihisa
    Inoue, Yukichi
    INTERNATIONAL JOURNAL CARDIOLOGY HYPERTENSION, 2020, 5
  • [34] Autoantibody Correlation Signatures in Fibromyalgia and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Association with Symptom Severity
    Ryabkova, Varvara A. A.
    Gavrilova, Natalia Y. Y.
    Poletaeva, Alina A. A.
    Pukhalenko, Alexander I. I.
    Koshkina, Irina A. A.
    Churilov, Leonid P. P.
    Shoenfeld, Yehuda
    BIOMEDICINES, 2023, 11 (02)
  • [35] Repetitive transcranial magnetic stimulation ameliorates symptoms in patients with myalgic encephalomyelitis (chronic fatigue syndrome)
    Miwa, Kunihisa
    Inoue, Yukichi
    IBRO NEUROSCIENCE REPORTS, 2023, 15 : 335 - 341
  • [36] The etiologic relation between disequilibrium and orthostatic intolerance in patients with myalgic encephalomyelitis (chronic fatigue syndrome)
    Miwa, Kunihisa
    Inoue, Yukichi
    JOURNAL OF CARDIOLOGY, 2018, 72 (3-4) : 261 - 264
  • [37] Immunoadsorption to remove β2 adrenergic receptor antibodies in Chronic Fatigue Syndrome CFS/ME
    Scheibenbogen, Carmen
    Loebel, Madlen
    Freitag, Helma
    Krueger, Anne
    Bauer, Sandra
    Antelmann, Michaels
    Doehner, Wolfram
    Scherbakov, Nadja
    Heidecke, Harald
    Reinke, Petra
    Volk, Hans-Dieter
    Grabowski, Patricia
    PLOS ONE, 2018, 13 (03):
  • [38] Metabolic Dysfunction in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Not Due to Anti-mitochondrial Antibodies
    Nilsson, Isabell
    Palmer, Jeremy
    Apostolou, Eirini
    Gottfries, Carl-Gerhard
    Rizwan, Muhammad
    Dahle, Charlotte
    Rosen, Anders
    FRONTIERS IN MEDICINE, 2020, 7
  • [39] Changes in DNA methylation profiles of myalgic encephalomyelitis/chronic fatigue syndrome patients reflect systemic dysfunctions
    Helliwell, A. M.
    Sweetman, E. C.
    Stockwell, P. A.
    Edgar, C. D.
    Chatterjee, A.
    Tate, W. P.
    CLINICAL EPIGENETICS, 2020, 12 (01)
  • [40] Analysis of post COVID-19 condition and its overlap with myalgic encephalomyelitis/chronic fatigue syndrome
    Sukocheva, Olga A.
    Maksoud, Rebekah
    Beeraka, Narasimha M.
    V. Madhunapantula, SabbaRao
    Sinelnikov, Mikhail
    Nikolenko, Vladimir N.
    Neganova, Margarita E.
    Klochkov, Sergey G.
    Kamal, Mohammad Amjad
    Staines, Donald R.
    Marshall-Gradisnik, Sonya
    JOURNAL OF ADVANCED RESEARCH, 2022, 40 : 179 - 196